Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Rapid weight loss from weight-loss drugs, not the drugs themselves, mainly causes hair loss.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

GLP-1 agonists may help treat certain skin conditions.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

A comprehensive, personalized approach is needed for treating female pattern hair loss and obesity, involving multiple medical disciplines and lifestyle changes.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

Hair loss from weight-loss treatments is usually temporary and reversible.

New therapies for rare skin diseases show promise but need more research.

Medications for PCOS don't seem to raise heart disease risk.

Treating hirsutism and acne in women with PCOS needs a personalized approach using oral contraceptives, antiandrogens, and sometimes metformin.

PCOS treatment should be personalized based on individual symptoms and health goals.

Semaglutide may help some skin disorders but can also cause skin issues.

A rash from semaglutide may be due to propylene glycol, not the drug itself.

Combining antidiabetic drugs, hormonal therapies, and lifestyle changes can improve health in women with PCOS.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

Combining lifestyle changes and medication is most effective for managing PCOS symptoms.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Tirzepatide may improve hair loss by reducing insulin resistance.

Women with PCOS have a higher risk of heart disease.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Weight loss improves PCOS symptoms and overall health.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Methylene blue helps hair growth by protecting hair stem cells from stress.